Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 181

1.

Fluoroquinolone heteroresistance in Mycobacterium tuberculosis: detection by genotypic and phenotypic assays in experimentally mixed populations.

Rigouts L, Miotto P, Schats M, Lempens P, Cabibbe AM, Galbiati S, Lampasona V, de Rijk P, Cirillo DM, de Jong BC.

Sci Rep. 2019 Aug 13;9(1):11760. doi: 10.1038/s41598-019-48289-9.

2.

Precision medicine and public health interventions: tuberculosis as a model?

Temesgen Z, Cirillo DM, Raviglione MC.

Lancet Public Health. 2019 Aug;4(8):e374. doi: 10.1016/S2468-2667(19)30130-6. No abstract available.

3.

Genome-based taxonomic revision detects a number of synonymous taxa in the genus Mycobacterium.

Tortoli E, Meehan CJ, Grottola A, Fregni Serpini G, Fabio A, Trovato A, Pecorari M, Cirillo DM.

Infect Genet Evol. 2019 Jul 26;75:103983. doi: 10.1016/j.meegid.2019.103983. [Epub ahead of print]

PMID:
31352146
4.

Same meat, different gravy: ignore the new names of mycobacteria.

Tortoli E, Brown-Elliott BA, Chalmers JD, Cirillo DM, Daley CL, Emler S, Floto RA, Garcia MJ, Hoefsloot W, Koh WJ, Lange C, Loebinger M, Maurer FP, Morimoto K, Niemann S, Richter E, Turenne CY, Vasireddy R, Vasireddy S, Wagner D, Wallace RJ Jr, Wengenack N, van Ingen J.

Eur Respir J. 2019 Jul 11;54(1). pii: 1900795. doi: 10.1183/13993003.00795-2019. Print 2019 Jul. No abstract available.

PMID:
31296783
5.

Acquisition of Cross-Resistance to Bedaquiline and Clofazimine following Treatment for Tuberculosis in Pakistan.

Ghodousi A, Rizvi AH, Baloch AQ, Ghafoor A, Khanzada FM, Qadir M, Borroni E, Trovato A, Tahseen S, Cirillo DM.

Antimicrob Agents Chemother. 2019 Aug 23;63(9). pii: e00915-19. doi: 10.1128/AAC.00915-19. Print 2019 Sep.

6.

App-based symptoms screening with Xpert MTB/RIF Ultra assay used for active tuberculosis detection in migrants at point of arrivals in Italy: The E-DETECT TB intervention analysis.

Barcellini L, Borroni E, Cimaglia C, Girardi E, Matteelli A, Marchese V, Stancanelli G, Abubakar I; members of the E-Detect TB Consortium, Cirillo DM.

PLoS One. 2019 Jul 1;14(7):e0218039. doi: 10.1371/journal.pone.0218039. eCollection 2019.

7.

Whole genome sequencing of Mycobacterium tuberculosis: current standards and open issues.

Meehan CJ, Goig GA, Kohl TA, Verboven L, Dippenaar A, Ezewudo M, Farhat MR, Guthrie JL, Laukens K, Miotto P, Ofori-Anyinam B, Dreyer V, Supply P, Suresh A, Utpatel C, van Soolingen D, Zhou Y, Ashton PM, Brites D, Cabibbe AM, de Jong BC, de Vos M, Menardo F, Gagneux S, Gao Q, Heupink TH, Liu Q, Loiseau C, Rigouts L, Rodwell TC, Tagliani E, Walker TM, Warren RM, Zhao Y, Zignol M, Schito M, Gardy J, Cirillo DM, Niemann S, Comas I, Van Rie A.

Nat Rev Microbiol. 2019 Sep;17(9):533-545. doi: 10.1038/s41579-019-0214-5. Review.

PMID:
31209399
8.

Emergence of two novel sequence types (3366 and 3367) NDM-1- and OXA-48-co-producing K. pneumoniae in Italy.

Gona F, Bongiorno D, Aprile A, Corazza E, Pasqua B, Scuderi MG, Chiacchiaretta M, Cirillo DM, Stefani S, Mezzatesta ML.

Eur J Clin Microbiol Infect Dis. 2019 Sep;38(9):1687-1691. doi: 10.1007/s10096-019-03597-w. Epub 2019 Jun 5.

PMID:
31165962
9.

Isoniazid Resistance in Mycobacterium tuberculosis Is a Heterogeneous Phenotype Composed of Overlapping MIC Distributions with Different Underlying Resistance Mechanisms.

Ghodousi A, Tagliani E, Karunaratne E, Niemann S, Perera J, Köser CU, Cirillo DM.

Antimicrob Agents Chemother. 2019 Jun 24;63(7). pii: e00092-19. doi: 10.1128/AAC.00092-19. Print 2019 Jul.

10.

Role and value of whole genome sequencing in studying tuberculosis transmission.

Nikolayevskyy V, Niemann S, Anthony R, van Soolingen D, Tagliani E, Ködmön C, van der Werf MJ, Cirillo DM.

Clin Microbiol Infect. 2019 Apr 11. pii: S1198-743X(19)30124-7. doi: 10.1016/j.cmi.2019.03.022. [Epub ahead of print] Review.

PMID:
30980928
11.

Lack of association of novel mutation Asp397Gly in aftB gene with ethambutol resistance in clinical isolates of Mycobacterium tuberculosis.

Giri A, Safi H, Cabibbe AM, Gupta S, Narang A, Tyagi G, Shrivastava K, Kumar C, Kumar Sharma N, Lingaraju S, Trovato A, Battaglia S, Cirillo DM, Bose M, Alland D, Varma-Basil M.

Tuberculosis (Edinb). 2019 Mar;115:49-55. doi: 10.1016/j.tube.2019.01.004. Epub 2019 Jan 25.

PMID:
30948176
12.

Building the framework for standardized clinical laboratory reporting of next generation sequencing data for resistance-associated mutations in Mycobacterium tuberculosis complex.

Tornheim JA, Starks AM, Rodwell TC, Gardy JL, Walker TM, Cirillo DM, Jayashankar L, Miotto P, Zignol M, Schito M.

Clin Infect Dis. 2019 Mar 18. pii: ciz219. doi: 10.1093/cid/ciz219. [Epub ahead of print]

PMID:
30883637
13.

Hospital outbreak due to Clostridium difficile ribotype 018 (RT018) in Southern Germany.

Berger FK, Gfrörer S, Becker SL, Baldan R, Cirillo DM, Frentrup M, Steglich M, Engling P, Nübel U, Mellmann A, Bischoff M, Gärtner B, von Müller L.

Int J Med Microbiol. 2019 May - Jun;309(3-4):189-193. doi: 10.1016/j.ijmm.2019.03.001. Epub 2019 Mar 5.

PMID:
30879971
14.

Exportation of MDR TB to Europe from Setting with Actively Transmitted Persistent Strains in Peru.

Acosta F, Agapito J, Cabibbe AM, Cáceres T, Sola C, Pérez-Lago L, Abascal E, Herranz M, Meza E, Klotoe B, Muñoz P, Rossolini GM, Bartoloni A, Tortoli E, Cirillo DM, Gotuzzo E, García de Viedma D.

Emerg Infect Dis. 2019 Mar;25(3):596-598. doi: 10.3201/eid2503.180574.

15.

Whole-Genome Sequencing of Drug-Resistant Mycobacterium tuberculosis Strains, Tunisia, 2012-2016.

Bouzouita I, Cabibbe AM, Trovato A, Daroui H, Ghariani A, Midouni B, Essalah L, Mehiri E, Cirillo DM, Saidi LS.

Emerg Infect Dis. 2019 Mar;25(3):538-546. doi: 10.3201/eid2503.181370.

16.

Drug-Resistant Tuberculosis, Lebanon, 2016 - 2017.

El Achkar S, Demanche C, Osman M, Rafei R, Ismail MB, Yaacoub H, Pinçon C, Duthoy S, De Matos F, Gaudin C, Trovato A, Cirillo DM, Hamze M, Supply P.

Emerg Infect Dis. 2019 Mar;25(3):564-568. doi: 10.3201/eid2503.181375.

17.

ASAP-GxNet project in Burkina Faso: fulfil country capacity gaps to ensure efficient utilisation of GeneXpert instruments in tuberculosis care and cascade.

Alagna R, Sawadogo TL, Combary A, Diandé S, Cirillo DM.

ERJ Open Res. 2019 Feb 1;5(1). pii: 00150-2018. doi: 10.1183/23120541.00150-2018. eCollection 2019 Feb.

18.

The Tuberculosis Network European Trials group (TBnet) ERS Clinical Research Collaboration: addressing drug-resistant tuberculosis through European cooperation.

van Leth F, Brinkmann F, Cirillo DM, Dheda K, Duarte R, Guglielmetti L, Kuksa L, Lange C, Mitnick C, Skrahina A, Zaman K, Bothamley G.

Eur Respir J. 2019 Jan 3;53(1). pii: 1802089. doi: 10.1183/13993003.02089-2018. Print 2019 Jan. No abstract available.

PMID:
30606765
19.

MTBseq: a comprehensive pipeline for whole genome sequence analysis of Mycobacterium tuberculosis complex isolates.

Kohl TA, Utpatel C, Schleusener V, De Filippo MR, Beckert P, Cirillo DM, Niemann S.

PeerJ. 2018 Nov 13;6:e5895. doi: 10.7717/peerj.5895. eCollection 2018.

20.

Implementing TB control in a rural, resource-limited setting: the stop-TB Italia project in Senegal.

Diaw MM, Ndiaye M, Riccardi N, Ungaro R, Alagna R, Cirillo DM, Codecasa L, Viscoli C, Nicolini LA, Besozzi G; StopTB Italia Onlus.

Multidiscip Respir Med. 2018 Nov 9;13:41. doi: 10.1186/s40248-018-0154-3. eCollection 2018.

21.

Can we predict tuberculosis cure? What tools are available?

Goletti D, Lindestam Arlehamn CS, Scriba TJ, Anthony R, Cirillo DM, Alonzi T, Denkinger CM, Cobelens F.

Eur Respir J. 2018 Nov 8;52(5). pii: 1801089. doi: 10.1183/13993003.01089-2018. Print 2018 Nov. Review.

22.

Automated detection of bacterial growth on 96-well plates for high-throughput drug susceptibility testing of Mycobacterium tuberculosis.

Fowler PW, Gibertoni Cruz AL, Hoosdally SJ, Jarrett L, Borroni E, Chiacchiaretta M, Rathod P, Lehmann S, Molodtsov N, Walker TM, Robinson E, Hoffmann H, Peto TEA, Cirillo DM, Smith GE, Crook DW.

Microbiology. 2018 Dec;164(12):1522-1530. doi: 10.1099/mic.0.000733. Epub 2018 Oct 23.

PMID:
30351270
23.

Screening for active and latent tuberculosis among asylum seekers in Italy: A retrospective cohort analysis.

Pontarelli A, Marchese V, Scolari C, Capone S, El-Hamad I, Donato F, Moioli R, Girardi E, Cirillo DM, Castelli F, Matteelli A.

Travel Med Infect Dis. 2019 Jan - Feb;27:39-45. doi: 10.1016/j.tmaid.2018.10.015. Epub 2018 Oct 19.

PMID:
30347248
24.

Multidrug-Resistant Tuberculosis in Côte d'Ivoire from 1995 to 2016: Results of National Surveys.

N'Guessan K, Ouassa T, Dean AS, Alagna R, Adagra GD, Ibode V, Cirillo DM, Kouakou J.

Eur J Microbiol Immunol (Bp). 2018 Aug 16;8(3):91-94. doi: 10.1556/1886.2018.00001. eCollection 2018 Sep 28.

25.

Integrating standardized whole genome sequence analysis with a global Mycobacterium tuberculosis antibiotic resistance knowledgebase.

Ezewudo M, Borens A, Chiner-Oms Á, Miotto P, Chindelevitch L, Starks AM, Hanna D, Liwski R, Zignol M, Gilpin C, Niemann S, Kohl TA, Warren RM, Crook D, Gagneux S, Hoffner S, Rodrigues C, Comas I, Engelthaler DM, Alland D, Rigouts L, Lange C, Dheda K, Hasan R, McNerney R, Cirillo DM, Schito M, Rodwell TC, Posey J.

Sci Rep. 2018 Oct 18;8(1):15382. doi: 10.1038/s41598-018-33731-1.

26.

Prediction of Susceptibility to First-Line Tuberculosis Drugs by DNA Sequencing.

CRyPTIC Consortium and the 100,000 Genomes Project, Allix-Béguec C, Arandjelovic I, Bi L, Beckert P, Bonnet M, Bradley P, Cabibbe AM, Cancino-Muñoz I, Caulfield MJ, Chaiprasert A, Cirillo DM, Clifton DA, Comas I, Crook DW, De Filippo MR, de Neeling H, Diel R, Drobniewski FA, Faksri K, Farhat MR, Fleming J, Fowler P, Fowler TA, Gao Q, Gardy J, Gascoyne-Binzi D, Gibertoni-Cruz AL, Gil-Brusola A, Golubchik T, Gonzalo X, Grandjean L, He G, Guthrie JL, Hoosdally S, Hunt M, Iqbal Z, Ismail N, Johnston J, Khanzada FM, Khor CC, Kohl TA, Kong C, Lipworth S, Liu Q, Maphalala G, Martinez E, Mathys V, Merker M, Miotto P, Mistry N, Moore DAJ, Murray M, Niemann S, Omar SV, Ong RT, Peto TEA, Posey JE, Prammananan T, Pym A, Rodrigues C, Rodrigues M, Rodwell T, Rossolini GM, Sánchez Padilla E, Schito M, Shen X, Shendure J, Sintchenko V, Sloutsky A, Smith EG, Snyder M, Soetaert K, Starks AM, Supply P, Suriyapol P, Tahseen S, Tang P, Teo YY, Thuong TNT, Thwaites G, Tortoli E, van Soolingen D, Walker AS, Walker TM, Wilcox M, Wilson DJ, Wyllie D, Yang Y, Zhang H, Zhao Y, Zhu B.

N Engl J Med. 2018 Oct 11;379(15):1403-1415. doi: 10.1056/NEJMoa1800474. Epub 2018 Sep 26.

27.

Height Measures: Evaluating Alternatives to Standing Height in the Ambulatory Setting.

Cirillo DM, Hart SK, Reich RR, Mason TM.

Clin J Oncol Nurs. 2018 Oct 1;22(5):529-533. doi: 10.1188/18.CJON.529-533.

PMID:
30239505
28.

Latent tuberculous infection among foreign-born individuals applying to shelters in the metropolitan area of Milan.

Barcellini L, Campisi D, Castellotti PF, Cugnata F, Ferrara G, Ferrarese M, Murgia N, Repossi A, Cirillo DM, Codecasa LR.

Int J Tuberc Lung Dis. 2018 Oct 1;22(10):1160-1165. doi: 10.5588/ijtld.18.0114.

PMID:
30236183
29.

Whole genome sequencing of Mycobacterium tuberculosis.

Cabibbe AM, Walker TM, Niemann S, Cirillo DM.

Eur Respir J. 2018 Nov 1;52(5). pii: 1801163. doi: 10.1183/13993003.01163-2018. Print 2018 Nov. Review. No abstract available.

PMID:
30209198
30.

Mycobacterium decipiens sp. nov., a new species closely related to the Mycobacterium tuberculosis complex.

Brown-Elliott BA, Simmer PJ, Trovato A, Hyle EP, Droz S, Buckwalter SP, Borroni E, Branda JA, Iana E, Mariottini A, Nelson J, Matteelli A, Toney NC, Scarparo C, de Man TJB, Vasireddy R, Gandhi RT, Wengenack NL, Cirillo DM, Wallace RJ, Tortoli E.

Int J Syst Evol Microbiol. 2018 Nov;68(11):3557-3562. doi: 10.1099/ijsem.0.003031. Epub 2018 Sep 11.

PMID:
30204586
31.

Drug resistance mechanisms and drug susceptibility testing for tuberculosis.

Miotto P, Zhang Y, Cirillo DM, Yam WC.

Respirology. 2018 Dec;23(12):1098-1113. doi: 10.1111/resp.13393. Epub 2018 Sep 6. Review.

32.

A case report of mucocutaneous tuberculosis after orthotopic liver transplantation: a challenging diagnosis.

Riccardi N, Cenderello G, Borroni E, Rutigliani M, Cirillo DM.

BMC Infect Dis. 2018 Aug 29;18(1):431. doi: 10.1186/s12879-018-3347-7.

33.

An evaluation framework for new tests that predict progression from tuberculosis infection to clinical disease.

Kik SV, Schumacher S, Cirillo DM, Churchyard G, Boehme C, Goletti D, Rangaka MX, Denkinger CM, Lienhardt C, Gilpin C, Matteelli A, Cobelens F.

Eur Respir J. 2018 Oct 25;52(4). pii: 1800946. doi: 10.1183/13993003.00946-2018. Print 2018 Oct.

PMID:
30139776
34.

Validating a 14-Drug Microtiter Plate Containing Bedaquiline and Delamanid for Large-Scale Research Susceptibility Testing of Mycobacterium tuberculosis.

Rancoita PMV, Cugnata F, Gibertoni Cruz AL, Borroni E, Hoosdally SJ, Walker TM, Grazian C, Davies TJ, Peto TEA, Crook DW, Fowler PW, Cirillo DM; CRyPTIC Consortiumfor the CRyPTIC Consortiumfor the CRyPTIC Consortium.

Antimicrob Agents Chemother. 2018 Aug 27;62(9). pii: e00344-18. doi: 10.1128/AAC.00344-18. Print 2018 Sep.

35.

Is sequencing better than phenotypic tests for the detection of pyrazinamide resistance?

Bouzouita I, Cabibbe AM, Trovato A, Draoui H, Ghariani A, Midouni B, Essalah L, Mehiri E, Cirillo DM, Slim-Saidi L.

Int J Tuberc Lung Dis. 2018 Jun 1;22(6):661-666. doi: 10.5588/ijtld.17.0715.

PMID:
29862951
36.

Towards tackling tuberculosis in vulnerable groups in the European Union: the E-DETECT TB consortium.

Abubakar I, Matteelli A, de Vries G, Zenner D, Cirillo DM, Lönnroth K, Popescu G, Barcellini L, Story A, Migliori GB.

Eur Respir J. 2018 May 10;51(5). pii: 1702604. doi: 10.1183/13993003.02604-2017. Print 2018 May. No abstract available.

PMID:
29748241
37.

Trend in rifampicin-, multidrug- and extensively drug-resistant tuberculosis in Italy, 2009-2016.

Mustazzolu A, Borroni E, Cirillo DM, Giannoni F, Iacobino A; Italian Multicentre Study on Resistance to Antituberculosis Drugs (SMIRA), Fattorini L.

Eur Respir J. 2018 Jul 19;52(1). pii: 1800070. doi: 10.1183/13993003.00070-2018. Print 2018 Jul. No abstract available.

PMID:
29724919
38.

ERS/ECDC Statement: European Union standards for tuberculosis care, 2017 update.

Migliori GB, Sotgiu G, Rosales-Klintz S, Centis R, D'Ambrosio L, Abubakar I, Bothamley G, Caminero JA, Cirillo DM, Dara M, de Vries G, Aliberti S, Dinh-Xuan AT, Duarte R, Midulla F, Solovic I, Subotic DR, Amicosante M, Correia AM, Cirule A, Gualano G, Kunst H, Palmieri F, Riekstina V, Tiberi S, Verduin R, van der Werf MJ.

Eur Respir J. 2018 May 17;51(5). pii: 1702678. doi: 10.1183/13993003.02678-2017. Print 2018 May.

PMID:
29678945
39.

Countrywide implementation of whole genome sequencing: an opportunity to improve tuberculosis management, surveillance and contact tracing in low incidence countries.

Cabibbe AM, Trovato A, De Filippo MR, Ghodousi A, Rindi L, Garzelli C, Baretti S, Allodi G, Mannino R, Rossolini GM, Bartoloni A, Tortoli E, Cirillo DM.

Eur Respir J. 2018 Jun 28;51(6). pii: 1800387. doi: 10.1183/13993003.00387-2018. Print 2018 Jun. No abstract available.

PMID:
29650560
40.

EUSeqMyTB to set standards and build capacity for whole genome sequencing for tuberculosis in the EU.

Tagliani E, Cirillo DM, Ködmön C, van der Werf MJ; EUSeqMyTB Consortium.

Lancet Infect Dis. 2018 Apr;18(4):377. doi: 10.1016/S1473-3099(18)30132-4. Epub 2018 Mar 21. No abstract available.

PMID:
29582760
41.

Genetic sequencing for surveillance of drug resistance in tuberculosis in highly endemic countries: a multi-country population-based surveillance study.

Zignol M, Cabibbe AM, Dean AS, Glaziou P, Alikhanova N, Ama C, Andres S, Barbova A, Borbe-Reyes A, Chin DP, Cirillo DM, Colvin C, Dadu A, Dreyer A, Driesen M, Gilpin C, Hasan R, Hasan Z, Hoffner S, Hussain A, Ismail N, Kamal SMM, Khanzada FM, Kimerling M, Kohl TA, Mansjö M, Miotto P, Mukadi YD, Mvusi L, Niemann S, Omar SV, Rigouts L, Schito M, Sela I, Seyfaddinova M, Skenders G, Skrahina A, Tahseen S, Wells WA, Zhurilo A, Weyer K, Floyd K, Raviglione MC.

Lancet Infect Dis. 2018 Jun;18(6):675-683. doi: 10.1016/S1473-3099(18)30073-2. Epub 2018 Mar 21. Erratum in: Lancet Infect Dis. 2018 Mar 27;:.

42.

Bedaquiline Phenotypic and Genotypic Susceptibility Testing, Work in Progress!

Tiberi S, Cabibbe AM, Tomlins J, Cirillo DM, Migliori GB.

EBioMedicine. 2018 Mar;29:11-12. doi: 10.1016/j.ebiom.2018.02.006. Epub 2018 Feb 8. No abstract available.

43.

Screening of migrants for tuberculosis identifies patients with multidrug-resistant tuberculosis but is not sufficient.

Helbling P, Kröger S, Haas W, Brusin S, Cirillo DM, Groenheit R, Guthmann JP, Soini H, Hendrickx D, van der Werf MJ.

Clin Microbiol Infect. 2018 Aug;24(8):918-919. doi: 10.1016/j.cmi.2018.03.015. Epub 2018 Mar 17. No abstract available.

44.

Role of Disputed Mutations in the rpoB Gene in Interpretation of Automated Liquid MGIT Culture Results for Rifampin Susceptibility Testing of Mycobacterium tuberculosis.

Miotto P, Cabibbe AM, Borroni E, Degano M, Cirillo DM.

J Clin Microbiol. 2018 Apr 25;56(5). pii: e01599-17. doi: 10.1128/JCM.01599-17. Print 2018 May.

45.

Alarming levels of multidrug-resistant tuberculosis in Ukraine: results from the first national survey.

Pavlenko E, Barbova A, Hovhannesyan A, Tsenilova Z, Slavuckij A, Shcherbak-Verlan B, Zhurilo A, Vitek E, Skenders G, Sela I, Cabibbe AM, Cirillo DM, de Colombani P, Dara M, Dean A, Zignol M, Dadu A.

Int J Tuberc Lung Dis. 2018 Feb 1;22(2):197-205. doi: 10.5588/ijtld.17.0254.

PMID:
29506617
46.

A cluster of multidrug-resistant Mycobacterium tuberculosis among patients arriving in Europe from the Horn of Africa: a molecular epidemiological study.

Walker TM, Merker M, Knoblauch AM, Helbling P, Schoch OD, van der Werf MJ, Kranzer K, Fiebig L, Kröger S, Haas W, Hoffmann H, Indra A, Egli A, Cirillo DM, Robert J, Rogers TR, Groenheit R, Mengshoel AT, Mathys V, Haanperä M, Soolingen DV, Niemann S, Böttger EC, Keller PM; MDR-TB Cluster Consortium.

Lancet Infect Dis. 2018 Apr;18(4):431-440. doi: 10.1016/S1473-3099(18)30004-5. Epub 2018 Jan 8. Erratum in: Lancet Infect Dis. 2018 Jan 10;:.

47.

A standardised method for interpreting the association between mutations and phenotypic drug resistance in Mycobacterium tuberculosis.

Miotto P, Tessema B, Tagliani E, Chindelevitch L, Starks AM, Emerson C, Hanna D, Kim PS, Liwski R, Zignol M, Gilpin C, Niemann S, Denkinger CM, Fleming J, Warren RM, Crook D, Posey J, Gagneux S, Hoffner S, Rodrigues C, Comas I, Engelthaler DM, Murray M, Alland D, Rigouts L, Lange C, Dheda K, Hasan R, Ranganathan UDK, McNerney R, Ezewudo M, Cirillo DM, Schito M, Köser CU, Rodwell TC.

Eur Respir J. 2017 Dec 28;50(6). pii: 1701354. doi: 10.1183/13993003.01354-2017. Print 2017 Dec.

48.

Culture and Next-generation sequencing-based drug susceptibility testing unveil high levels of drug-resistant-TB in Djibouti: results from the first national survey.

Tagliani E, Hassan MO, Waberi Y, De Filippo MR, Falzon D, Dean A, Zignol M, Supply P, Abdoulkader MA, Hassangue H, Cirillo DM.

Sci Rep. 2017 Dec 15;7(1):17672. doi: 10.1038/s41598-017-17705-3.

49.

Staphylococcus aureus Impacts Pseudomonas aeruginosa Chronic Respiratory Disease in Murine Models.

Cigana C, Bianconi I, Baldan R, De Simone M, Riva C, Sipione B, Rossi G, Cirillo DM, Bragonzi A.

J Infect Dis. 2018 Mar 5;217(6):933-942. doi: 10.1093/infdis/jix621.

PMID:
29216403
50.

Xpert MTB/RIF Ultra for detection of Mycobacterium tuberculosis and rifampicin resistance: a prospective multicentre diagnostic accuracy study.

Dorman SE, Schumacher SG, Alland D, Nabeta P, Armstrong DT, King B, Hall SL, Chakravorty S, Cirillo DM, Tukvadze N, Bablishvili N, Stevens W, Scott L, Rodrigues C, Kazi MI, Joloba M, Nakiyingi L, Nicol MP, Ghebrekristos Y, Anyango I, Murithi W, Dietze R, Lyrio Peres R, Skrahina A, Auchynka V, Chopra KK, Hanif M, Liu X, Yuan X, Boehme CC, Ellner JJ, Denkinger CM; study team.

Lancet Infect Dis. 2018 Jan;18(1):76-84. doi: 10.1016/S1473-3099(17)30691-6. Epub 2017 Nov 30. Erratum in: Lancet Infect Dis. 2018 Feb 21;:.

Supplemental Content

Loading ...
Support Center